You guys probably already know, but I've just noticed a new ABN Amro's report on Alchemia's web page.
http://www.alchemia.com.au/investors/analystreports/ABN_AMRO_ACL51011.pdf
They have a valuation of $3.52, but because of the way aussies view biotechs, a price target of $1.76. Still don't know why they value it so low!
They have a probability of success 70%, with most of the risk being accessed as licensing delays. As APP are the experts at getting ANDA's through, I think we will be ok on that score.
Wish Wilsons, Hartleys or Taylor Collison would cover this stock.
- Forums
- ASX - By Stock
- abn amro $3.52 valuation
You guys probably already know, but I've just noticed a new ABN...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable